Representative Robert Bresnahan, Jr. (R-Pennsylvania) recently bought shares of Humana Inc. NYSE: HUM. In a filing disclosed on March 27th, the Representative disclosed that they had bought between $1,001 and $15,000 in Humana stock on February 25th. The trade occurred in the Representative's "JP MORGAN BROKERAGE ACCOUNT" account.
Representative Robert Bresnahan, Jr. also recently made the following trade(s):
- Purchased $1,001 - $15,000 in shares of Intuit NASDAQ: INTU on 3/7/2025.
- Sold $1,001 - $15,000 in shares of Tesla NASDAQ: TSLA on 3/6/2025.
- Purchased $1,001 - $15,000 in shares of SEA NYSE: SE on 3/5/2025.
- Sold $1,001 - $15,000 in shares of Credo Technology Group NASDAQ: CRDO on 3/4/2025.
- Purchased $1,001 - $15,000 in shares of Meta Platforms NASDAQ: META on 3/4/2025.
- Purchased $1,001 - $15,000 in shares of Twilio NYSE: TWLO on 3/4/2025.
- Sold $15,001 - $50,000 in shares of Alibaba Group NYSE: BABA on 3/4/2025.
- Purchased $1,001 - $15,000 in shares of Zoom Video Communications NASDAQ: ZM on 3/4/2025.
- Purchased $1,001 - $15,000 in shares of Intel NASDAQ: INTC on 3/3/2025.
- Purchased $1,001 - $15,000 in shares of Snowflake NYSE: SNOW on 3/3/2025.
Humana Stock Down 0.1 %
Shares of Humana stock traded down $0.23 during midday trading on Monday, hitting $264.35. The company had a trading volume of 1,201,515 shares, compared to its average volume of 1,756,635. Humana Inc. has a 52-week low of $213.31 and a 52-week high of $406.46. The stock has a market capitalization of $31.91 billion, a P/E ratio of 26.57, a P/E/G ratio of 2.05 and a beta of 0.57. The company has a 50 day moving average of $270.14 and a 200 day moving average of $273.49. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76.
Humana (NYSE:HUM - Get Free Report) last announced its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, topping analysts' consensus estimates of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. On average, equities analysts predict that Humana Inc. will post 16.47 earnings per share for the current fiscal year.
Humana Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be paid a $0.885 dividend. The ex-dividend date is Friday, March 28th. This represents a $3.54 annualized dividend and a dividend yield of 1.34%. Humana's payout ratio is 35.58%.
Wall Street Analysts Forecast Growth
HUM has been the subject of a number of recent research reports. Royal Bank of Canada reissued an "outperform" rating and set a $283.00 price objective on shares of Humana in a research report on Wednesday, February 12th. StockNews.com cut Humana from a "buy" rating to a "hold" rating in a research report on Tuesday, March 18th. Cantor Fitzgerald reissued a "neutral" rating and issued a $290.00 target price on shares of Humana in a report on Wednesday, February 12th. JPMorgan Chase & Co. reduced their price objective on shares of Humana from $257.00 to $256.00 and set a "neutral" rating for the company in a research note on Tuesday, February 18th. Finally, Truist Financial increased their price target on Humana from $260.00 to $290.00 and gave the stock a "hold" rating in a research note on Monday, January 6th. Eighteen analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus price target of $285.68.
Check Out Our Latest Research Report on Humana
Hedge Funds Weigh In On Humana
Hedge funds and other institutional investors have recently bought and sold shares of the company. Pinnacle Wealth Management Advisory Group LLC increased its holdings in shares of Humana by 3.6% in the 4th quarter. Pinnacle Wealth Management Advisory Group LLC now owns 1,070 shares of the insurance provider's stock valued at $272,000 after purchasing an additional 37 shares in the last quarter. Atlas Brown Inc. increased its holdings in Humana by 0.6% in the fourth quarter. Atlas Brown Inc. now owns 6,352 shares of the insurance provider's stock valued at $1,611,000 after buying an additional 38 shares in the last quarter. Mather Group LLC. lifted its position in shares of Humana by 21.0% during the 4th quarter. Mather Group LLC. now owns 236 shares of the insurance provider's stock valued at $60,000 after acquiring an additional 41 shares during the period. Capital Advisors Ltd. LLC boosted its stake in shares of Humana by 26.1% during the 4th quarter. Capital Advisors Ltd. LLC now owns 208 shares of the insurance provider's stock worth $53,000 after acquiring an additional 43 shares in the last quarter. Finally, Retirement Planning Co of New England Inc. boosted its stake in shares of Humana by 4.7% during the 4th quarter. Retirement Planning Co of New England Inc. now owns 966 shares of the insurance provider's stock worth $245,000 after acquiring an additional 43 shares in the last quarter. 92.38% of the stock is currently owned by hedge funds and other institutional investors.
Insider Activity at Humana
In other Humana news, insider Timothy S. Huval sold 3,703 shares of the company's stock in a transaction on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total value of $948,930.78. Following the sale, the insider now owns 8,181 shares of the company's stock, valued at approximately $2,096,463.06. This represents a 31.16 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 0.37% of the stock is currently owned by company insiders.
About Representative Bresnahan
Rob Bresnahan Jr. (Republican Party) is a member of the U.S. House, representing Pennsylvania's 8th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.
Bresnahan (Republican Party) is running for re-election to the U.S. House to represent Pennsylvania's 8th Congressional District. He declared candidacy for the 2026 election.
Rob Bresnahan Jr. was born in Kingston, Pennsylvania. He earned a B.S. in business administration, management and operations from the University of Scranton in 2012. His career experience includes working as the chief financial officer and CEO of a family business, an electrical contracting company.
Humana Company Profile
(
Get Free Report)
Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Featured Articles
Before you consider Humana, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Humana wasn't on the list.
While Humana currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
